What's breaking now, across thousands of outlets.
Key PointsAnalyst opinions and sales projections for weight loss and type 2 diabetes drug VK2735 vary widely, reflecting both promise and uncertainty.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
ASIC’s proposal would extend leverage limits and protections against negative balances to certain derivatives settled in digital assets.
October rate-hike odds have slumped, but analysts say Treasury yields at two-decade highs are still keeping a lid on risk appetite.
Spain has given the go-ahead to a new savings plan which, in theory, allows its residents to invest up to […]
Only four qualified stock brokers have joined the PaRRVA platform so far, while several industry players have raised concerns over high costs and limited adoption
KUALA LUMPUR, Oct 12 — The ringgit closed higher against the US dollar and other major currencies today, supported...
Tel Aviv Stock Exchange’s pitch is aided by US investors’ preference for AI giants: “New York is no longer an option.”
